Gastrointestinal Pathology — MCQs

Gastrointestinal Pathology Indian Medical PG Practice Questions and MCQs

Question 31: In classic Barrett's esophagus, what is the minimum length of columnar epithelium in the distal esophagus?

A. Greater than 1 cm
B. Greater than 2 cm
C. Greater than 3 cm (Correct Answer)
D. Greater than 4 cm

Explanation: **Explanation:** **Barrett’s Esophagus (BE)** is a metaplastic change where the normal stratified squamous epithelium of the esophagus is replaced by simple columnar epithelium (with goblet cells) due to chronic gastroesophageal reflux disease (GERD) [1]. **Why Option C is Correct:** Traditionally, Barrett’s esophagus is classified based on the length of the metaplastic segment proximal to the gastroesophageal junction: * **Long-segment (Classic) Barrett’s:** Defined as a columnar-lined segment extending **greater than 3 cm** above the gastroesophageal junction. * **Short-segment Barrett’s:** Defined as a segment measuring **less than 3 cm**. The "Classic" designation specifically refers to the long-segment variety, which carries a higher risk of progression to esophageal adenocarcinoma [1]. **Analysis of Incorrect Options:** * **Options A & B:** While segments of 1 cm or 2 cm are clinically significant and classified as "Short-segment BE," they do not meet the criteria for "Classic" or "Long-segment" BE. * **Option D:** While a 4 cm segment is indeed Barrett's, the standard diagnostic threshold for the "Classic" definition starts at >3 cm. **High-Yield NEET-PG Pearls:** * **Hallmark Histology:** Presence of **Goblet cells** (Intestinal metaplasia) is the diagnostic gold standard [1]. * **Stain:** **Alcian Blue** at pH 2.5 is used to highlight the acidic mucin in goblet cells. * **Risk:** It is a premalignant condition for **Esophageal Adenocarcinoma** (not squamous cell carcinoma) [1]. * **Endoscopy:** Appears as "salmon-pink" velvety tongues of mucosa extending upward from the GE junction. * **Prague Criteria:** Used for endoscopic grading (C = Circumferential extent; M = Maximal extent). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 348-349.

Question 32: Which of the following is NOT true about GIST?

A. Most common in the stomach (Correct Answer)
B. Necrosis and ulceration may be present
C. PET is used to assess response to therapy
D. Typically well circumscribed

Explanation: **Explanation:** The question asks for the statement that is **NOT** true regarding Gastrointestinal Stromal Tumors (GIST). 1. **Why Option A is the "Correct" Answer (The False Statement):** Actually, the statement "Most common in the stomach" is a **true** fact about GIST. In the context of this specific question format (where A is marked as the correct choice for being "not true"), there may be a typographical error in the question stem or options. **Factually, 60-70% of GISTs occur in the stomach**, followed by the small intestine (20-30%). If the question intended to find the false statement, Option A would typically be the *incorrect* choice because it is a well-established truth [1]. 2. **Analysis of Other Options:** * **Option B (Necrosis/Ulceration):** Large GISTs frequently outgrow their blood supply, leading to central necrosis and overlying mucosal ulceration, which often presents as GI bleeding. * **Option C (PET Scan):** FDG-PET is highly sensitive for GIST. It is the gold standard for assessing early biochemical response to Tyrosine Kinase Inhibitors (TKIs) like Imatinib, often showing changes before size reduction is visible on CT [1]. * **Option D (Well-circumscribed):** Grossly, GISTs appear as fleshy, well-demarcated submucosal masses, though they lack a true capsule. **High-Yield Clinical Pearls for NEET-PG:** * **Origin:** Derived from **Interstitial Cells of Cajal** (the pacemaker cells of the gut) [1]. * **Markers:** **c-KIT (CD117)** is the most specific marker (95% positive). **DOG1** is used for c-KIT negative cases. * **Genetics:** Most have mutations in the *KIT* gene; a subset has *PDGFRA* mutations [1]. * **Treatment:** Surgical resection is primary; **Imatinib** (TKI) is the targeted therapy of choice for unresectable or metastatic cases [1]. * **Histology:** Can be Spindle cell type (70%) or Epithelioid type. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 782-784.

Question 33: Which of the following is not associated with pseudomembranous colitis?

A. Toxin A is responsible for clinical manifestations
B. Toxin B is responsible for clinical manifestations
C. Gross blood in stools is common (Correct Answer)
D. Summit lesion is an early histopathological finding

Explanation: **Explanation:** Pseudomembranous colitis (PMC) is an inflammatory condition of the colon, most commonly caused by an overgrowth of *Clostridioides difficile* following broad-spectrum antibiotic use (e.g., clindamycin, fluoroquinolones) [1]. **Why Option C is the correct answer:** In PMC, the diarrhea is typically **profuse and watery**, often accompanied by abdominal cramps and fever. While fecal leukocytes are common, **gross (visible) blood in the stool is rare**. If significant hematochezia is present, clinicians should consider alternative diagnoses like Ulcerative Colitis or ischemic colitis [1]. **Analysis of other options:** * **Options A & B:** *C. difficile* produces two potent exotoxins. **Toxin A (Enterotoxin)** causes fluid secretion and mucosal inflammation, while **Toxin B (Cytotoxin)** causes significant mucosal damage by disrupting the actin cytoskeleton. Both are essential for the clinical manifestation of the disease. * **Option D:** The **"Summit Lesion"** (or "Volcano Lesion") is the pathognomonic early histopathological finding. It consists of an eruption of purulent exudate (neutrophils, fibrin, and necrotic debris) from a superficial site of mucosal ulceration, resembling a volcano. These lesions later coalesce to form the characteristic yellow-green pseudomembranes. **NEET-PG High-Yield Pearls:** * **Drug of Choice:** Oral Vancomycin or Fidaxomicin (Metronidazole is now a second-line agent for non-severe cases). * **Diagnosis:** Detection of *C. difficile* toxins in stool (GDH assay/NAAT) is preferred over culture. * **Morphology:** Grossly, the colon shows raised, yellowish-white plaques (pseudomembranes) on an erythematous mucosa [1]. * **Risk Factor:** Most common inciting antibiotic historically is Clindamycin, but currently, Cephalosporins and Fluoroquinolones are frequently implicated. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 786-787.

Question 34: All are features of early gastric carcinoma except?

A. Mucosal involvement
B. Submucosal involvement
C. Muscularis propria involvement (Correct Answer)
D. Dysplasia with carcinoma in situ

Explanation: ### Explanation **Early Gastric Carcinoma (EGC)** is defined by its depth of invasion rather than its surface area or the presence of lymph node metastasis [1]. **1. Why "Muscularis propria involvement" is the correct answer:** By definition, Early Gastric Carcinoma is a lesion that is confined to the **mucosa** or **submucosa**, regardless of whether regional lymph nodes are involved [1]. Once the tumor penetrates into the **muscularis propria**, it is classified as **Advanced Gastric Carcinoma** [1]. Therefore, muscularis propria involvement is the defining feature that excludes a diagnosis of EGC. **2. Analysis of incorrect options:** * **Mucosal involvement (Option A):** This is the earliest stage of EGC (T1a). The tumor is limited to the epithelium and lamina propria [1]. * **Submucosal involvement (Option B):** EGC includes tumors that have invaded the submucosa (T1b) but have not yet reached the muscularis propria [1]. * **Dysplasia with carcinoma in situ (Option D):** These are precursor stages or the earliest manifestations of malignancy confined to the basement membrane, fitting well within the spectrum of "early" neoplastic changes [2]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Prognosis:** EGC has an excellent prognosis, with a 5-year survival rate exceeding 90-95% [3]. * **Lymph Node Metastasis:** Note that EGC **can** have lymph node metastasis (seen in ~10-20% of cases involving the submucosa); however, it is still classified as "Early" as long as the primary tumor hasn't breached the submucosa [1]. * **Most Common Site:** The **lesser curvature** of the antrum and pylorus. * **Gross Classification:** The Japanese Society of Gastroenterological Endoscopy classifies EGC into three types: Type I (Protruded), Type II (Superficial), and Type III (Excavated). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 355-356. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 209-210. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 349-350.

Question 35: Gastrointestinal stromal tumors arise from which of the following?

A. Smooth muscle
B. Nerve cells
C. Interstitial cells of Cajal (Correct Answer)
D. Vascular endothelium

Explanation: **Explanation:** **Gastrointestinal Stromal Tumors (GISTs)** are the most common mesenchymal neoplasms of the gastrointestinal tract. **Why the correct answer is right:** GISTs originate from the **Interstitial Cells of Cajal (ICCs)**, which are the "pacemaker cells" of the gut located in the muscularis propria [1]. These cells coordinate peristalsis. The hallmark of GIST is a gain-of-function mutation in the **c-KIT proto-oncogene** (CD117), which encodes a receptor tyrosine kinase. This mutation leads to constitutive signaling for cell proliferation [1]. **Why the incorrect options are wrong:** * **Smooth muscle:** Tumors arising from smooth muscle are called Leiomyomas or Leiomyosarcomas. While GISTs were historically misclassified as such, they are distinct entities. * **Nerve cells:** Tumors of neural origin include Schwannomas or Neurofibromas. * **Vascular endothelium:** Tumors arising from the lining of blood vessels are called Hemangiomas or Angiosarcomas. **High-Yield Clinical Pearls for NEET-PG:** * **Most Common Site:** Stomach (60%), followed by the small intestine (30%). * **Immunohistochemistry (IHC):** **CD117 (c-KIT)** is the most sensitive and specific marker (positive in 95% of cases). **DOG1** (Discovered on GIST-1) is another highly specific marker used for KIT-negative cases. * **Genetics:** Approximately 80% have *KIT* mutations; 8% have *PDGFRA* mutations [1]. * **Treatment:** The targeted therapy of choice is **Imatinib** (a tyrosine kinase inhibitor), which has revolutionized the management of metastatic or unresectable GIST. * **Histology:** Can show spindle cell (most common) or epithelioid patterns. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 782-783.

Question 36: Which of the following is NOT true about ulcerative colitis?

A. Rectum is typically involved
B. Pseudopolyps can be present
C. Pancolitis can occur
D. Noncaseating granulomas are found (Correct Answer)

Explanation: **Explanation:** The presence of **noncaseating granulomas** is a hallmark histological feature of **Crohn’s Disease** [3], not Ulcerative Colitis (UC). In UC, the inflammation is strictly limited to the mucosa and submucosa [1]; it does not form granulomas. If granulomas are seen in a biopsy, it strongly points toward Crohn’s or intestinal tuberculosis [4]. **Analysis of Options:** * **Option A (Rectum involved):** This is a classic feature of UC. It is a disease of the colon that starts in the rectum (**proctitis**) and spreads proximally in a **continuous, symmetrical** fashion without "skip lesions" [2]. * **Option B (Pseudopolyps):** These are common in UC. They are islands of regenerating, bulging residual mucosa surrounded by areas of extensive ulceration and mucosal atrophy. * **Option C (Pancolitis):** While UC can be limited to the rectum or left colon, it frequently involves the entire large intestine (pancolitis) [2]. In severe pancolitis, "backwash ileitis" may also occur [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Depth of Involvement:** UC is **mucosal/submucosal** [2], whereas Crohn’s is **transmural** [5]. * **Microscopy:** Look for **crypt abscesses** (neutrophils in crypt lumens) and crypt distortions in UC [1]. * **Complications:** UC has a higher risk of **Toxic Megacolon** and **Colorectal Carcinoma** compared to Crohn’s. * **Serology:** UC is typically associated with **p-ANCA**, while Crohn’s is associated with **ASCA**. * **Smoking Paradox:** Smoking is protective in UC but a risk factor for Crohn’s. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 809. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 367-368. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 806-807. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 366-367. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 365-366.

Question 37: Which of the following colonic polyps is not premalignant?

A. Juvenile polyps (Correct Answer)
B. Hamartomatous polyps associated with Peutz-Jeghers syndrome
C. Villous adenoma
D. Tubular adenomas

Explanation: **Explanation:** The potential for malignancy in colonic polyps depends on their histological architecture and genetic drivers. **1. Why Juvenile Polyps are the correct answer:** Juvenile polyps are **sporadic, solitary hamartomatous lesions** typically found in the rectum of children [1]. They are characterized by "cystically dilated glands" filled with mucin and inflammatory debris [4]. Because they are focal malformations rather than true neoplasms, sporadic juvenile polyps have **no malignant potential**. (Note: This differs from *Juvenile Polyposis Syndrome*, where the sheer number of polyps increases cancer risk due to associated germline mutations) [1]. **2. Why the other options are incorrect:** * **Villous & Tubular Adenomas:** These are true neoplastic polyps. All adenomas are considered premalignant [3]. The risk of progression to adenocarcinoma is highest in **Villous adenomas** (due to size and high degree of dysplasia) compared to tubular ones [2]. * **Peutz-Jeghers Syndrome (PJS):** While the individual hamartomatous polyps in PJS are not technically premalignant themselves, the syndrome is associated with a significantly **increased risk of various cancers** (colorectal, pancreatic, breast, and ovarian) due to the *STK11* mutation [4]. Therefore, in a clinical context, they are managed with high suspicion. **High-Yield Clinical Pearls for NEET-PG:** * **Adenoma-Carcinoma Sequence:** The most common pathway for sporadic CRC, involving *APC* (gatekeeper), *KRAS*, and *p53* mutations [3]. * **Size Matters:** Any polyp >2 cm has a 40-50% risk of harboring malignancy [2]. * **Histology:** Villous = "Villainous" (highest risk); Tubular = "Typical" (lower risk) [2]. * **Hyperplastic Polyps:** Generally benign and found in the rectosigmoid, but must be distinguished from "Sessile Serrated Adenomas," which are premalignant [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 813. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 371-372. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 821-822. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 813-814.

Question 38: In Mallory Weiss syndrome, the rupture commonly occurs at which location?

A. Gastric cardia (Correct Answer)
B. Esophageal mucosa
C. Gastroesophageal junction
D. Gastroduodenal junction

Explanation: **Explanation:** Mallory-Weiss syndrome (MWS) is characterized by longitudinal mucosal lacerations at the gastroesophageal junction or the gastric cardia. While these tears are often associated with the junction, the **gastric cardia** is the most common specific site of rupture (occurring in approximately 75% of cases). **1. Why Gastric Cardia is Correct:** The pathophysiology involves a sudden, massive increase in intra-abdominal pressure (e.g., forceful vomiting, retching, or coughing). During this process, the stomach contents are forced against a closed or poorly relaxed lower esophageal sphincter. The gastric cardia, being the most distensible part of the proximal stomach, bears the brunt of this pressure, leading to longitudinal mucosal tears that often cross the Z-line. [1] **2. Analysis of Incorrect Options:** * **B. Esophageal mucosa:** While tears can extend into the distal esophagus, they rarely originate there in isolation. Isolated esophageal rupture is more characteristic of **Boerhaave Syndrome** (transmural rupture). [2] * **C. Gastroesophageal junction:** This is a common site, but statistically, the tears are more frequently localized to the gastric side of the junction (the cardia) rather than being strictly confined to the junctional line. * **D. Gastroduodenal junction:** This area is not involved in MWS; it is the site for peptic ulcers or pyloric stenosis. **3. Clinical Pearls for NEET-PG:** * **Presentation:** Painless hematemesis following bouts of retching (often in alcoholics or patients with bulimia). [2] * **Diagnosis:** Gold standard is **Upper GI Endoscopy**, which reveals linear mucosal streaks. * **Mallory-Weiss vs. Boerhaave:** MWS is a **mucosal/submucosal** tear (partial thickness), whereas Boerhaave syndrome is a **transmural** (full thickness) rupture leading to pneumomediastinum. [2] * **Management:** Most cases (80-90%) bleed minimally and heal spontaneously without surgical intervention. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 346-347. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 761-762.

Question 39: Which of the following is NOT a characteristic of Menetrier disease?

A. Excessive protein loss
B. Decreased mucus production (Correct Answer)
C. Acquired, premalignant condition
D. H. pylori is a predisposing factor in adults

Explanation: **Explanation:** **Ménétrier Disease** is a rare, acquired hypertrophic gastropathy characterized by massive enlargement of gastric rugae (resembling cerebral convolutions) due to the over-expression of **Transforming Growth Factor-alpha (TGF-α)** [1]. **Why "Decreased mucus production" is the correct answer:** In Ménétrier disease, TGF-α causes selective hyperplasia of surface mucous cells (foveolar cells). This leads to **foveolar hyperplasia** and a significant **increase in mucus production**, not a decrease [1]. The excessive mucus secretion, combined with the loss of tight junctions, leads to the leakage of plasma proteins into the gastric lumen. **Analysis of other options:** * **A. Excessive protein loss:** This is a hallmark feature. The condition is often called a "protein-losing gastropathy," leading to hypoalbuminemia and peripheral edema. * **C. Acquired, premalignant condition:** It is an acquired disorder (not congenital) and is associated with an increased risk of gastric adenocarcinoma in adults (approx. 2–15%) [1]. * **D. H. pylori as a predisposing factor:** In adults, *H. pylori* infection is frequently associated with the disease. In contrast, the pediatric form is often transient and triggered by Cytomegalovirus (CMV) infection [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Histology:** Characterized by "corkscrew" appearance of elongated foveolar glands and **atrophy of parietal cells** (leading to achlorhydria/hypochlorhydria) [1]. * **Pathogenesis:** Excessive activation of the **EGFR (Epidermal Growth Factor Receptor)** pathway by TGF-α. * **Treatment:** Cetuximab (anti-EGFR monoclonal antibody) is used in severe cases. * **Classic Triad:** Giant gastric folds + Hypoalbuminemia + Achlorhydria. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 775-776.

Question 40: What is the most common tumor occurring in the appendix?

A. Carcinoid tumor (Correct Answer)
B. Melanoma
C. Adenocarcinoma
D. Mucinous tumor

Explanation: **Explanation:** The **Carcinoid tumor** (well-differentiated neuroendocrine tumor) is the most common primary neoplasm of the appendix, accounting for approximately 50–85% of all appendiceal tumors [1][2]. These tumors typically arise from the subepithelial neuroendocrine cells (Kulchitsky cells) and are most frequently discovered incidentally during an appendectomy [1]. **Why the other options are incorrect:** * **Melanoma:** Primary melanoma of the appendix is extremely rare. While the GI tract can be a site for metastatic melanoma, it is never the most common tumor of the appendix. * **Adenocarcinoma:** This is the second most common primary malignancy of the appendix but is significantly less frequent than carcinoid tumors. It usually presents in older age groups and mimics the clinical presentation of acute appendicitis. * **Mucinous tumor:** These include a spectrum from mucocele to mucinous cystadenocarcinoma. While they are clinically significant due to the risk of **Pseudomyxoma Peritonei** (jelly belly), they occur less frequently than carcinoid tumors. **High-Yield Clinical Pearls for NEET-PG:** * **Location:** Most appendiceal carcinoids are located at the **distal tip** of the appendix. * **Prognosis:** Most are <1 cm in size and have an excellent prognosis; they rarely metastasize [1]. * **Carcinoid Syndrome:** Appendiceal carcinoids rarely cause carcinoid syndrome unless there are extensive liver metastases. * **Histology:** Characterized by "islands" or nests of uniform small cells with "salt and pepper" chromatin [2]. They stain positive for **Chromogranin A** and **Synaptophysin**. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 375-376. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 780-782.

Practice by Chapter

Oral Cavity and Esophageal Pathology

Practice Questions

Gastritis and Peptic Ulcer Disease

Practice Questions

Inflammatory Bowel Disease

Practice Questions

Malabsorption Syndromes

Practice Questions

Vascular Disorders of Intestine

Practice Questions

Diverticular Disease

Practice Questions

Intestinal Obstruction

Practice Questions

Gastrointestinal Infections

Practice Questions

Polyps and Neoplasms

Practice Questions

Appendiceal Pathology

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free